Page 458 Acute Pain Management
P. 458




There
is
a
need
to
understand
different
cultures
when
considering
pain
assessment
and

management.
This
extends
beyond
the
language
spoken,
because
an
individual’s
culture
also

influences
their
beliefs,
expectations,
methods
of
communication
and
norms
of
behaviour,
as

do
the
culture
and
attitudes
of
the
health
care
provider
(Green
et
al,
2003;
Davidhizar
&
Giger,

2004).
It
is
important
for
clinicians
to
be
aware
of
both
verbal
and
non‐verbal
indicators
of
pain

and
be
sensitive
to
both
emotive
and
stoic
behaviours
in
an
individual’s
response.
Some

cultural
attitudes
may
limit
pain‐relief
seeking
behaviour.
For
example,
it
may
be
perceived
by

some
patients
as
inappropriate
to
use
a
nurse’s
time
to
ask
for
analgesics
or
asking
for
pain

relief
may
be
seen
as
a
weakness
(Green
et
al,
2003).


Communication
problems
may
make
it
difficult
to
adequately
help
non‐English
speaking

patients
with
interactive
pain
management
(eg
PCA
use,
requesting
analgesia
when
needed),

gain
consent
for
invasive
analgesic
techniques
(eg
epidural
or
plexus
catheters)
and
assess

their
degree
of
pain
(Howe
et
al,
1998
Level
IV).
When
language
is
an
obstacle,
care
should
be

used
when
enlisting
non‐professional
interpreters
to
translate,
because
family
members
and

friends
of
the
patient
may
impose
their
own
values
when
conveying
the
information
to
the

clinician,
and
the
patient
may
be
reluctant
to
openly
express
themselves
in
front
of
people

they
know.

Cultural
differences
in
response
to
pain
in
both
the
experimental
and
clinical
settings
have

been
reported.
A
review
of
studies
investigating
differences
in
responses
to
experimentally

induced
pain
found
that
cultural
differences
influenced
pain
tolerance
but
not
pain
threshold,

and
concluded
that
intrinsic
difficulties
in
the
translation
of
pain
descriptors
between
different

cultures
makes
pain
tolerance
the
more
relevant
pain
measure
(Zatzick
&
Dimsdale,
1990).
In
a

comparison
of
experimental
pain
sensitivity
in
three
ethnic
groups,
African
Americans
and

Hispanic
Americans
showed
a
greater
sensitivity
to
laboratory‐evoked
pain
compared
with

non‐Hispanic
White
Americans
(Rahim‐Williams
et
al,
2007
Level
III‐2).
Similarly,
African
American

women
were
more
sensitive
to
ischaemic
pain
than
non‐Hispanic
white
women
(Klatzkin
et
al,

2007
Level
III‐2).
However,
the
implications
of
these
results
for
the
clinical
setting
are
unclear.

A
systemic
review
looked
at
the
effect
of
patient
race
and
ethnicity
on
pain
assessment
and

management
across
a
variety
of
clinical
pain
settings
(Cintron
&
Morrison,
2006
Level
III‐3).

Marked
disparities
in
effective
pain
treatment
were
reported;
African
Americans
and
Hispanics

were
less
likely
to
receive
opioid
analgesics,
and
were
more
likely
to
have
their
pain

undertreated
compared
with
white
patients.


Differences
have
been
reported
in
patients
of
different
ethnic
groups
attending
emergency

departments
and
requiring
analgesia.
A
review
of
the
treatment
of
pain
in
United
States

CHAPTER
11
 the
period
1993
to
2005,
but
that
white
patients
with
pain
were
more
likely
than
black,

emergency
departments
showed
that
opioid
prescribing
for
pain‐related
visits
increased
over


Hispanic
or
Asian
patients
to
receive
an
opioid,
and
that
these
differences
did
not
diminish

over
time
(Pletcher
et
al,
2008
Level
III‐3).
This
disparity
was
reported
for
all
types
of
pain
visits,

was
more
pronounced
with
increasing
pain
intensity,
and
was
unaffected
by
adjustment
for

pain
severity.


Prescription
of
PCA
and
PCA
prescription
details
also
varied
with
patient
ethnicity
(Ng
et
al,

1996
Level
III‐3;
Salamonson
&
Everett,
2005
Level
III‐3),
although
the
actual
self‐administered

doses
of
opioid
were
similar
(Ng
et
al,
1996
Level
IV).
After
Caesarean
section,
significant
ethnic

group
differences
were
noted
in
reported
pain
and
morphine
consumption;
pain
scores
and

morphine
doses
were
higher
in
Indian
patients
compared
with
Chinese
and
Malay
patients

even
after
controlling
for
age,
body
mass
index,
and
duration
of
operation
(Tan
et
al,
2008

Level
III‐2).





410
 Acute
Pain
Management:
Scientific
Evidence

   453   454   455   456   457   458   459   460   461   462   463